Embolic protection device

Information

  • Patent Grant
  • 8945169
  • Patent Number
    8,945,169
  • Date Filed
    Tuesday, March 14, 2006
    19 years ago
  • Date Issued
    Tuesday, February 3, 2015
    10 years ago
Abstract
An embolic protection device is provided for deployment within a body vessel to collect embolic debris there from. The device includes a filter for collecting the embolic debris and a frame for supporting the filter. The frame generally defines a closed loop that has a collapsed state and an opened state. Furthermore, the frame includes a tube portion that receives an opening means to open the closed loop from the collapsed state to the opened state.
Description
BACKGROUND

1. Field of the Invention


The invention relates generally to medical devices. More specifically, the invention relates to intravascular distal embolic protection devices.


2. Related Technology


Embolic protection devices are percutaneously placed in a body vessel to prevent emboli from traveling and creating an undesirable embolism, e.g., pulmonary embolism. For example, vena cava filters are used for trapping emboli in the vena cava filter to prevent pulmonary embolism. Also, anti-platelet agents and anticoagulants may be used to breakdown blood clots. Moreover, snares and baskets (e.g., stone retrieval baskets) are used for retrieving urinary calculi. Additionally, occlusion coils are commonly used to occlude aneurysms and accumulate thrombi in a body vessel.


Treatments for a stenotic lesion provide a potential in releasing blood clots and other thrombi plaque in the vasculature of the patient. One example is the treatment for a carotid artery stenosis. Generally, carotid artery stenosis is the narrowing of the carotid arteries, the main arteries in the neck that supply blood to the brain. Carotid artery stenosis (also called carotid artery disease) is a relatively high risk factor for ischemic stroke. The narrowing is usually caused by plaque build-up in the carotid artery.


Carotid angioplasty is a more recently developed treatment for carotid artery stenosis. This treatment uses balloons and/or stents to open a narrowed artery. Carotid angioplasty is a procedure that can be performed via a standard percutaneous transfemoral approach with the patient anesthetized using light intravenous sedation. At the stenosis area, an angioplasty balloon is delivered to predilate the stenosis in preparation for stent placement. The balloon is then removed and exchanged via catheter for a stent delivery device. Once in position, a stent is deployed across the stenotic area. If needed, an additional balloon can be placed inside the deployed stent for post-dilation to make sure the struts of the stent are pressed firmly against the inner surface of the vessel wall. During the stenosis procedure however, there is a risk of such blood clots and thrombi being undesirably released into the blood flow within the vasculature.


Therefore, distal embolic protection devices, such as occlusive devices and filters, have been developed to trap and to prevent the downstream travel of the blood clots and thrombi. The filters are typically advanced downstream of a site that is to be treated and then opened into an opened state to increase the filter area. The blood clots and thrombi can be captured in the opened filter while blood is still able to flow therethrough.


However, filter devices may fail to completely open within the blood vessel, leaving gaps between the filter outer surface and the blood vessel inner surface. These gaps may permit the above-described blood clots and thrombi to flow past the filter, unoccluded. As a result, the unoccluded blood clots and thrombi may thereby compromise the blood flow at a location distal from the treatment site.


Thus, there is a need to improve the opening of the filter device within the blood vessel to effectively capture the unoccluded blood clots and thrombi.


SUMMARY

In one aspect of the present invention, an embolic protection device is provided to collect embolic debris from within a body vessel. Generally, the device includes a filter for collecting embolic debris and a frame for supporting the filter. The frame generally defines a closed loop that has a collapsed state and an opened state. Furthermore, the frame includes a tube portion that receives an opening means to open the closed loop from the collapsed state to the opened state.


In another aspect of the present invention, the closed loop includes a circumferential outer surface that engages the body vessel in a substantially fluid-tight connection when the closed loop is in the opened state. The outer surface defines a substantially circular shape when the closed loop is in the opened state. Generally, the closed loop is substantially torus-shaped in the opened state.


In yet another aspect of the present invention, the device further includes a connecting portion that is in fluid communication with the closed loop. More specifically, the connecting portion is connected to the closed loop and extends away therefrom in a direction that is substantially parallel with a longitudinal axis of the body vessel. The connecting portion may also extend radially away from the closed loop.


In another aspect of the present invention, the device further includes a guide wire that extends along the body vessel longitudinal axis. The guide wire is slidably coupled with the connecting portion such as to permit the device to travel along the longitudinal axis to its desired location within the body vessel.


In yet another aspect of the present invention, the embolic protection device includes a locator device having radiopaque properties. The radiopaque properties of the locator device permit a device user, such as a medical professional, to locate the embolic protection device within a patient's body. Furthermore, the embolic protection device is preferably delivered into the body vessel via a delivery device that receives the closed loop in the collapsed state. More preferably, the delivery device is a catheter.


The present invention may also include a second frame that defines a second closed loop that supports the filter and that is positioned distally of the above-described frame. The second closed loop has a collapsed state and an opened state. More specifically, the second closed loop includes a tube portion for receiving an opening means and for opening the closed loop into the opened state, similarly to the above-described closed loop.


In one aspect of the present invention, the opening means for opening the frame is a fluid that is injected into the tube portion to inflate the closed loop into the opened state. Preferably, the fluid is a saline solution that is injected through the connecting portion and into the frame. The tube portion may each have expandable internal volumes that increase when the fluid is injected therein. Furthermore, the tube portion may be composed of a generally elastic material to further permit the expansion. The fluid may also be used in the above-described design having first and second frames.


In another aspect of the present invention, the opening means for opening the first and second frames is an opening member received by the tube portion to open the closed loop into the opened state. Preferably, the opening member is a wire having an axial stiffness that is substantially greater than its radial stiffness. The stiffness coefficients of the wire permit navigation of the wire through the body vessels. The wire may be a hollow tube to improve the ratio of stiffness coefficients and to minimize part weight. Additionally, in the above-described design having first and second frames, the embolic protection device may include a second opening member that is received by the second frame.


In yet another aspect of the present invention, the frame includes a telescoping portion that is received within a receiving portion of the frame. The telescoping portion is slideable within the receiving portion such as to adjust a radius of the opened state closed loop. More specifically, as the fluid fills the tube portion of the frame and applies a force onto the telescoping portion the frame radially opens towards the blood vessel walls.


Further objects, features and advantages of this invention will become readily apparent to persons skilled in the art after a review of the following description, with reference to the drawings and claims that are appended to and form a part of this specification.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an environmental side view of an embolic protection device having a frame and a filter opened into opened states and embodying the principles of the present invention, where the embolic protection device is shown located within a partially cut-away blood vessel;



FIG. 2 is a cross-sectional view taken along line 2-2 in FIG. 1 showing the embolic protection device opened into the opened state by a fluid located within a tube portion of the frame;



FIG. 3 is a cross-sectional view taken along line 3-3 in FIG. 2, showing the fluid located within the tube portion of the frame;



FIG. 4 is a cross-sectional view taken along line 4-4 in FIG. 2, showing a telescoping portion of the frame being received within a receiving portion of the frame;



FIG. 5 is a plan view of the embolic protection device positioned within a delivery device, where the frame is deflated into a collapsed state from the substantial removal of the fluid from the tube portion;



FIG. 6 shows a plan view of the embolic protection device deployed from the delivery device, where the frame is deflated into the collapsed state;



FIG. 7 is a cross-sectional view taken along line 7-7 in FIG. 6 showing the embolic protection device deflated into the collapsed state;



FIG. 8 is a cross-sectional view taken along line 8-8 in FIG. 6 showing the tube portion of the frame having a decreased internal volume from the substantial removal of the fluid from the tube portion;



FIG. 9 is a cross-sectional view, similar to that shown in FIG. 2, of an alternative design embodying the principles of the present invention, including a wire received within the tube portion to open the frame into the opened state;



FIG. 10 is an enlarged cross-sectional view taken along line 10-10 in FIG. 9, showing the wire received within the tube portion of the frame;



FIG. 11 is an enlarged cross-sectional view similar to that shown in FIG. 9, showing a hollow wire received within the tube portion of the frame;



FIG. 12 is a plan view of an embolic protection device, similar to that shown in FIG. 1, of an alternative design embodying the principles of the present invention, including first and second frames opened into an opened state to open the filter;



FIG. 13 is a cross-sectional view taken along line 13-13 in FIG. 12 showing the embolic protection device opened into the opened state by the fluid located within the tube portions of the first and second frames; and



FIG. 14 is an enlarged cross-sectional view similar to that shown in FIG. 13, showing a hollow wire received within the tube portions of the first and second frames.





DETAILED DESCRIPTION

Embodiments of the present invention generally provide distal protection devices, distal protection apparatus, and methods for capturing emboli in a body vessel during angioplasty for treatment of a stenosis. One particular stenosis is a carotid artery stenosis. The embodiments solve the concerns of current stenosis treatments, such as the relatively high risks of surgery and the potential release of emboli into the vasculature during the stenosis procedure. Embodiments of the present invention provide a relatively low risk approach to capturing emboli released during a stenosis procedure, e.g., balloon angioplasty.


Referring now to the drawings, FIG. 1 shows an embolic protection device 10 positioned within a body vessel, such as a blood vessel 12 that has a blood flow therethrough in a direction generally indicated by reference numeral 14. The embolic device 10 includes a filter 16 and is positioned downstream of emboli 18, such as blood clots and plaque fragments, to trap and to prevent the downstream travel of the emboli 18, thereby reducing the likelihood of an embolism or of the downstream blood vessels becoming blocked. As will be discussed in more detail below, the filter 16 operates similarly to a sieve, having openings 20 that permit blood to flow therethrough while preventing the emboli 18 from doing the same.


The filter 16 is composed of a mesh or a web-like material 22, but any suitable material may be used. More specifically, the filter material 22 is preferably strong enough to avoid rupture during use and thin enough to conveniently fit within the blood vessel 12. Furthermore, the filter material 22 is preferably sufficiently flexible such that the filter 16 is able to conform to various shapes and configurations, as may be needed to properly engage the blood vessel 12.


The filter 16 includes a proximally-located mouth portion 24 that is substantially opened to an opened state 26 for receiving the emboli 18. Preferably, the embolic device 10 forms a substantially fluid-tight seal 30 with the blood vessel when the mouth portion 24 is in the opened state 26. The seal 30 may be formed by the mouth portion, the filter 16, or both. The seal 30 prevents emboli 18 from flowing around the filter 16 and from potentially causing the above-described conditions.


The filter 16 further includes a tail portion 29 located distally of the mouth portion 24. The tail portion 29 is substantially closed, such as to permit blood to flow through the openings 20, while simultaneously preventing emboli 18 from doing the same. Therefore, the emboli 18 are collected within the tail portion 29.


The mouth portion 24 is held in the opened state 26 by a frame 32 that extends around the perimeter of the mouth portion 26. The frame 32 is collapsible into a collapsed state 33, as shown in FIGS. 5 and 6, such as to permit blood flow 14 between the frame 32 and the blood vessel inner walls 36. As will be discussed in more detail below, the frame 32 is typically in the collapsed state 33 while delivering the device 10 into a desired location of the blood vessel 12 and while removing the device 10 from the desired location. The frame 32 is preferably composed of a flexible material such as plastic or of a compliant material such as rubber. Alternatively, the frame 32 is composed of a plurality of generally rigid sections that are movable with respect to each other. Additionally, any sufficient collapsible design that permits delivery of the device 10 into the blood vessel 12 may be used.


The frame 32 forms an annular closed loop 34 that is positioned within the filter 16 to open the mouth portion 24 towards an inner wall 36 of the blood vessel 12. Alternatively, the filter 16 may be connected to the radially inner surface of the closed loop 34. A first portion 38 of the frame 32 is connected to a second portion 40 of the frame such that the closed loop 34 defines a continuous path 37. The closed loop 34 shown in FIG. 2 is generally circular, but any suitable shape and size may be used. The first and second portions 38, 40 are connected by any suitable means, such as by welding, adhesives, bonding (such as through heat treatment), or mechanical fasteners. Alternatively, the frame 32 is a single, unitary component.


The closed loop 34 design improves the seal 30 between the frame 32 and the blood vessel 12. More specifically, a free, unconnected portion of the frame would be able to freely flow downstream rather than tightly engaging the blood vessel 12.


The closed loop 34 includes an outer circumferential surface 42 that forms the substantially fluid-tight seal 30 with the blood vessel 12 when the frame 32 is in the opened state 26. The inner walls 36 of blood vessels 12 typically have a generally circular cross-section. Therefore, to effectively form the substantially fluid-tight seal 30, the outer surface 42 of the closed loop 34 also has a generally circular shape when the frame 32 is in the opened state 26. Furthermore, the closed loop 34 includes an inner circumferential surface 44 corresponding to the shape of the outer circumferential surface 42 such that the opened state 26 closed loop 34 is substantially torus-shaped.


The closed loop 34 is able to open to the opened state 26 by receiving an opening means. More specifically, the closed loop 34 is defined by a tube 46 having a tube portion 48 that defines an internal volume 49 and that is able to receive the opening means. The opening means may be any fluid or solid component that is suitable for opening the closed loop 34 in the radial direction 28. Acceptable fluids include, but are not limited to, saline and water, and acceptable solids include, but are not limited to, a wire and a tube.


In one design, shown in FIGS. 2 and 3, the opening means is a fluid 50 located within the tube portion 48 that causes the closed loop 34 to open in the radial direction 28. More specifically, as the tube portion 48 of the closed loop 34 fills with the fluid 50, the circumferential length of the closed loop 34 along the path 37 is maximized, thereby causing the radius 52 of the closed loop 34 to increase. The fluid 50 shown in the Figures is a saline solution, but any suitable fluid may be used.


The medical professional using the embolic protection device 10 is able to position the closed loop 34 by controlling the radius 52 of the closed loop 34 via a connecting portion 66 extending away from the closed loop 34. More specifically, the connecting portion 66 shown in FIGS. 1-4 includes a lumen 68 that receives the fluid 50 and that is in fluid communication with the closed loop 34 tube portion 48. Therefore, the medical professional is able to inject the fluid into the closed loop 34 via the connecting portion 66. The connecting portion 66 shown in the Figures includes a first portion generally intersecting a centerpoint 69 of the frame 32 and a second portion extending radially from the first portion to connect to the closed loop 34. Alternatively, the connecting portion 66 may be radially off-set from the centerpoint 69. In another design, the frame 32 includes a valve (not shown) to force the connecting portion 66 to inflate or open.


The connecting portion 66 and the frame 32 preferably each have shape memory such as to naturally conform to a desired position when in the opened state 26. More specifically, the connecting portion 66 and frame 32 are preferably positioned substantially perpendicular to each other such that a plane defined by the frame 32 is normal to the connecting portion 66 or are connected by a curved portion that generally connects two perpendicular portions. This configuration improves the seal 30 between the frame 32 and the blood vessel 12 because it urges the frame 32 to lie along a plane that is perpendicular to a longitudinal axis 53 of the blood vessel 12. Stated another way, the plane of the closed loop is preferably non-parallel to the longitudinal axis 53 of the blood vessel 12 and is most preferably perpendicular to the longitudinal axis 53.


Blood vessels 12 typically vary significantly in size and in shape. Therefore the radius 52 of the opened state 26 frame is preferably variable to effectively form the seal 30. More specifically, the frame 32 preferably includes a mechanism that permits the variation of the opened state radius 52.


Referring to FIG. 4, one such mechanism is a telescoping portion 54 slidably received within the tube 46 to permit variation of the opened state radius 52. The telescoping portion 54 forms a generally fluid-tight seal 56 with the inner surface of the tube 46 to prevent the fluid 50 from flowing between the respective components 54, 46. As a result, when the tube 46 becomes filled with fluid, a force 58 is applied onto he telescoping portion 54. The force 58 causes the telescoping portion 54 to move along the path 37, thereby increasing the circumferential length and the opened state radius 52 of the frame 32.


The telescoping portion 54 and/or the tube 46 may include a hard stop mechanism (not shown) that prevents the circumferential length from expanding beyond a particular size. More specifically, the hard stop mechanism prevents the telescoping portion 54 from exiting the tube 46. During operation of the embolic protection device 10, the telescoping portion 54 will stop moving when the force 58 from the fluid flow is generally equal to a force between the expanding tube 46 and the blood vessel inner wall 36. Furthermore, the telescoping portion 54 will also stop moving when the hard stop is engaged. The hand stop is preferably positioned so that the closed loop 34 is able to expand to form the seal 30 before the hand stop is engaged.


Referring back to FIG. 3, another mechanism for varying the opened state 26 closed loop radius 52 is a variable internal diameter 60 of the tube 46. For example, as shown in FIG. 3, the tube may be composed of an elastic material 62 such that the internal diameter 60 of the tube 46 is expandable. Therefore, when an increased volume of the fluid 50 is inserted within the tube 46, the internal diameter 60 and an external diameter 64 of the tube 46 increase and cause the opened state 26 closed loop radius 52 to increase. The closed loop 34 in this design may define a continuous fluid flow path along the path 37 such that the first portion 38 and the second portion 40 are in fluid connection with each other.


The medical professional using the embolic protection device 10 is also able to control the position of the embolic protection device 10 via a guide wire 70 and a connecting sleeve 72. More specifically, the connecting portion 66 is connected to the connecting sleeve 72, which slidably receives the guide wire 70. Therefore, the embolic protection device 10 is able to travel through the blood vessels in a direction generally parallel to the guide wire 70. The guide wire 70 intersects the filter 16 adjacent to the tail portion 29 thereof, which preferably includes a sealing component 74 to permit sliding movement between the filter 16 and the guide wire 70 while preventing emboli 18 from flowing therebetween.


The connecting sleeve 72 also preferably includes a locator device having radiopaque properties to permit the medical professional to more effectively track the location of the device 10 within the blood vessels 12. More specifically, the connecting sleeve 72 includes a coating of radiopaque material 76 that is visible through the patient's body with the assistance of detection equipment. The locator device is particularly beneficial during the delivery of the embolic protection device 10 into the desired location of the blood vessel 12 and during the removal of the device 10 from the same.


Referring now to FIGS. 1-3 and 6-8, the details of the opened state 26 and the collapsed state 33 will now be discussed in more detail. Preferably, the closed loop 34 has the opened state radius 52 (FIG. 2) when in the opened state 26 and a closed state radius 80 (FIG. 7) when in the collapsed state 33. As discussed above, the opened state radius 52 is substantially equal to that of the blood vessel 12, while the closed state radius 80 is substantially smaller than that of the blood vessel 12. Therefore, when the frame 32 is in the collapsed state 33 a gap 82 is present between the frame 32 and the blood vessel 12, permitting the embolic protection device 10 to travel through the blood vessel 12 as desired. As also discussed above, the collapsed state 33 is particularly desirable during the delivery the embolic protection device 10 into the desired location of the blood vessel 12 and during the removal of the device 10 from the same.


Furthermore, if the frame 32 is made of an elastic material, the internal volume of the closed loop may also vary as the opening means is inserted into the tube portion 48. The tube portion 48 defines the first internal volume 49 (FIG. 3) when the frame 32 is in the opened state 26 and a second internal volume 84 (FIG. 8) when in the collapsed state 33. The first internal volume 49 is preferably substantially greater than the second internal volume 84 due to the fluid 50 located within the tube portion 48 during the opened state 26. More specifically, the varying internal volume may occur for one or both of the following reasons. First, the fluid 50 is preferably removed from within the tube portion 48 when the frame is in the collapsed state 33, thereby creating a partial vacuum and a reduced volume within the tube portion 48 during this state 33. Secondly, the fluid 50 preferably causes expansion of the compliant walls of the tube 26 during the opened state 26, thereby increasing the first internal volume 49. When the frame 32 is in the collapsed state 33, all or a substantial portion of the air is also removed from the tube portion 48 so that the tube portion 48 can be more easily filled and also to minimize or prevent air from entering the blood vessel 12 in the case of a ruptured tube portion 48.


Referring now to FIGS. 5 and 6, the procedure for deployment of the embolic protection device 10 will now be discussed in more detail. The embolic protection device 10 preferably includes a delivery device, such as a catheter 86, for positioning the embolic protection device 10 within the blood vessel 12 at the desired location. More specifically, as shown in FIG. 5, the catheter 86 is inserted into the blood vessel 12 at a location downstream of the emboli 18 while the embolic protection device 10 is located within the catheter 86 in the collapsed state 33. Then, as shown in FIG. 6, the embolic protection device 10 remains in the collapsed state 33 and is released from the catheter 86 and is permitted to flow along the blood stream to its desired location. Next, the catheter 86 is removed from the blood vessel 12 and the embolic protection device 10 is opened into the opened state 26 by the medical professional. Alternatively, the catheter 86 remains within the blood vessel 12 after the deployment of the embolic protection device 10, as is the case with many catheters that are configured to deploy balloon catheter along with the embolic protection device 10.


In another design, shown in FIGS. 9-11, the opening means is an opening member, such as a wire 88, located within the tube portion 48 that causes the closed loop 34 to open in the radial direction 28. More specifically, the wire 88 is fed into the tube portion 48 to cause the closed loop 34 to open in the radial direction 28. The wire 88 preferably has an axial stiffness in the axial direction 90 that is greater than its radial stiffness in the radial direction 92 to permit the wire 88 to negotiate the bending path through the tube 46. Furthermore, as shown in FIG. 11, the opening member may be a hollow tube 94 to decrease the radial stiffness in the radial direction 92′ and to reduce component weight and cost.


In this embodiment, the tube portion 48 of the connecting portion 66 also preferably receives the wire 88. Furthermore, the connecting portion 66 and the closed loop 34 are connected to each other such that the medical professional can easily feed the wire 88 through the connecting portion 66 and into the closed loop 34.


Additionally, this embodiment may include a mechanism that permits the variation of the opened state radius 52. More specifically, the device 10 may include the telescoping portion 54 slidably received within the tube 46 to permit variation of the opened state radius 52. However, instead of being moved forward by a fluid force, the telescoping portion 54 in this embodiment is driven forward by the wire 88. Alternatively, the device 10 may include the tube 46 having a flexible internal diameter 60. However, instead of being radially opened by fluid pressure, the internal diameter 60 is increased by the wire 88 having a larger diameter than the tube 46.


Referring now to FIGS. 12-14, another embodiment of the present invention will now be discussed. More specifically, the embolic protection device 10 in FIG. 12 includes a second frame 96 defining a second closed loop 97 having a collapsed state (not shown) and an opened state 99 similar to the frame 32 described above. Furthermore, the second frame 96 is connected to a second connecting portion 98.


The first and second frames 32, 96 of the embolic protection device 10 shown in FIGS. 12 and 13 are opened into the respective opened states 26, 99 by the fluid 50 located within the tube portions of the tubes 46. In this design, the respective connecting portions 66, 98 of the respective frames 32, 96 are both in fluid communication with each other such that the medical professional can control the inflation of both frames 32, 96 simultaneously. Alternatively, other suitable designs may be used.


The first and second frames 32, 96 of the embolic protection device 10 shown in FIG. 14 are opened into the respective opened states 26, 99 by the wires 88a, 88b located within the tube portions of the tubes 46. In this design, the respective connecting portions 66, 98 of the respective frames 32, 96 are not internally connected with each other so the two wires 88a, 88b can be used to independently control the inflation of both frames 32, 96. Alternatively, other suitable designs may be used.


It is therefore intended that the foregoing detailed description be regarded as illustrative rather than limiting, and that it be understood that it is the following claims, including all equivalents, that are intended to define the spirit and scope of this invention.

Claims
  • 1. An embolic protection device for collecting embolic debris within a body vessel having an inner wall, the embolic protection device comprising: a tubular frame having a lumen and a longitudinal axis, wherein a portion of the frame forms an annular closed loop having a collapsed state and an opened state;a telescoping portion having an end and being slidably received within the lumen of the closed loop of the frame to open the closed loop from the collapsed state to the opened state;a connecting portion including a first portion radially connected to the tubular frame and a second portion extending from the first portion to connect to the closed loop, the second portion being disposed coaxially with the tubular frame, the first portion being radially off-set from the centerpoint; anda filter connected to the frame to collect the embolic debris, the filter having a proximally located mouth portion, the annular closed loop being positioned within the filter to open the mouth portion towards the inner wall of the body vessel;wherein a radius of the opened state closed loop is adjustable based on a force applied to the end the telescoping portion by a fluid within the lumen of the frame, the force moving the telescoping portion along the longitudinal axis of the tubular frame with the fluid flowing from the connecting portion to the tubular frame.
  • 2. An embolic protection device as in claim 1, wherein the closed loop includes a first radius measured perpendicularly to a longitudinal axis of the body vessel when the closed loop is in the collapsed state and having a second radius measured perpendicularly to the longitudinal axis when the closed loop is in the opened state, wherein the second radius is greater than the first radius.
  • 3. An embolic protection device as in claim 1, wherein the closed loop includes a circumferential outer surface engaging the body vessel in a fluid-tight connection when the closed loop is in the opened state.
  • 4. An embolic protection device as in claim 1, wherein the closed loop is torus-shaped when the closed loop is in the opened state.
  • 5. An embolic protection device as in claim 1, wherein the connecting portion is in fluid communication with and extending away from the closed loop.
  • 6. An embolic protection device as in claim 5, further comprising a guide wire slidably coupled with the connecting portion.
  • 7. An embolic protection device as in claim 6, further comprising a locator device having radiopaque properties that is coupled with the closed loop.
  • 8. An embolic protection device as in claim 5, further comprising a delivery device that receives the closed loop in the collapsed state.
  • 9. An embolic protection device as in claim 1, further comprising a second frame defining a second closed loop having a collapsed state and an opened state, wherein the second frame is located distally of the frame.
  • 10. An embolic protection device for collecting embolic debris within a body vessel having an inner wall, the embolic protection device comprising: a tubular frame having a centerpoint, a lumen, and a longitudinal axis, wherein a portion of the frame forms an annular closed loop having a collapsed state and an opened state, the lumen configured to receive a fluid to inflate the closed loop into the opened state;a connecting portion including a first portion radially connected to the tubular frame and a second portion disposed coaxially with the tubular frame, the first portion being one of generally intersecting the centerpoint and radially off-set from the centerpoint; anda filter connected to the frame to collect the embolic debris, the filter having a proximally located mouth portion, the annular closed loop being positioned within the filter to open the mouth portion towards the inner wall of the body vessel;the frame including a telescoping portion having an end and being slidably received within the lumen of the closed loop such that a radius of the opened state closed loop is adjustable based on a force applied to the end the telescoping portion by the fluid that flows from the connecting portion to the tubular frame, the force moving the telescoping portion along the longitudinal axis of the tubular frame.
  • 11. An embolic protection device as in claim 10, wherein the tubular frame includes a tube portion, the tube portion of the frame defines a first internal volume when the closed loop is in the collapsed state, the tube portion of the frame defines a second internal volume when the closed loop is in the opened state, and the second internal volume is greater than the first internal volume.
  • 12. An embolic protection device as in claim 10, wherein the tube portion is composed of an elastic material.
  • 13. An embolic protection device as in claim 10, wherein the connecting portion is in fluid communication with and extends away from the closed loop, wherein the tube portion defines a continuous flow path around the closed loop and wherein the flow path is in fluid communication with the connecting portion.
  • 14. An embolic protection device as in claim 10, further comprising a second frame defining a second closed loop having a collapsed state and an opened state, wherein the second frame is located distally of the frame, and wherein the filter is connected to the frame and the second frame.
  • 15. An embolic protection device for collecting embolic debris within a body vessel, the embolic protection device comprising: a tubular frame having a lumen and a longitudinal axis, wherein a portion of the frame forms an annular closed loop having a collapsed state and an opened state, the lumen of the frame configured to receive a fluid;a connecting portion including a first portion radially connected to the tubular frame and a second portion disposed coaxially with the tubular frame, the first portion being one of generally intersecting the centerpoint and radially off-set from the centerpoint; andan opening member having an end and being received by the lumen of the closed loop of the frame to open the closed loop into the opened state based on a force applied to the end of the opening member by the fluid that flows from the connecting portion to the tubular frame, the force moving the opening member along the longitudinal axis of the tubular frame; anda filter coupled with the closed loop to collect the embolic debris, the filter having a proximally located mouth portion, the annular closed loop being positioned within the filter to open the mouth portion towards the inner wall of the body vessel.
  • 16. An embolic protection device as in claim 15, wherein the opening member includes a wire.
  • 17. An embolic protection device as in claim 1, wherein the telescoping portion forms a fluid-tight seal with an inner surface of the tubular frame.
  • 18. An embolic protection device as in claim 1, further comprising a hard stop mechanism that prevents the telescoping portion from exiting the receiving portion.
  • 19. An embolic protection device as in claim 10, wherein the telescoping portion forms a fluid-tight seal with an inner surface of the tubular frame.
  • 20. An embolic protection device as in claim 15, wherein the opening member forms a fluid-tight seal with an inner surface of the tubular frame.
  • 21. The device of claim 10 wherein the second portion extends radially from the first portion when the first portion generally intersects the centerpoint.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims benefit of U.S. Provisional Application No. 60/661,731, filed Mar. 15, 2005 entitled Embolic Protection Device.

US Referenced Citations (876)
Number Name Date Kind
3108593 Glassman Oct 1963 A
3334629 Cohn Aug 1967 A
3472230 Fogarty Oct 1969 A
3547103 Cook Dec 1970 A
3635223 Klieman Jan 1972 A
3923065 Nozick et al. Dec 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3978863 Fettel et al. Sep 1976 A
3996938 Clark, III Dec 1976 A
4425908 Simon Jan 1984 A
4456000 Schjeldahl et al. Jun 1984 A
4494531 Gianturco Jan 1985 A
4548206 Osborne Oct 1985 A
4561439 Bishop et al. Dec 1985 A
4562039 Koehler Dec 1985 A
4604094 Shook Aug 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4646736 Auth Mar 1987 A
4650472 Bates Mar 1987 A
4665906 Jervis May 1987 A
4669464 Sulepov Jun 1987 A
4688553 Metals Aug 1987 A
4723549 Wholey et al. Feb 1988 A
4727873 Mobin-Uddin Mar 1988 A
4732152 Wallsten et al. Mar 1988 A
4817600 Herms et al. Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4832055 Palestrant May 1989 A
4846794 Hertzer Jul 1989 A
4848343 Wallsten et al. Jul 1989 A
4873978 Ginsburg Oct 1989 A
4943297 Saveliev et al. Jul 1990 A
4957501 Lahille et al. Sep 1990 A
4990156 Lefebvre Feb 1991 A
4998916 Hammerslag et al. Mar 1991 A
5053008 Bajaj Oct 1991 A
5059205 El-Nounou et al. Oct 1991 A
5069226 Yamauchi et al. Dec 1991 A
5078726 Kreamer Jan 1992 A
5100423 Fearnot Mar 1992 A
5108418 Lefebvre Apr 1992 A
5108419 Reger et al. Apr 1992 A
5112347 Taheri May 1992 A
5129890 Bates et al. Jul 1992 A
5129910 Phan et al. Jul 1992 A
5133733 Rasmussen et al. Jul 1992 A
5147379 Sabbaghian et al. Sep 1992 A
5152777 Goldberg Oct 1992 A
5160342 Reger Nov 1992 A
5163927 Woker et al. Nov 1992 A
5203772 Hammerslag et al. Apr 1993 A
5234458 Metais Aug 1993 A
5242462 El-Nounou Sep 1993 A
5243996 Hall Sep 1993 A
5251640 Osborne Oct 1993 A
5263964 Purdy Nov 1993 A
5300086 Gory et al. Apr 1994 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5344427 Cottenceau et al. Sep 1994 A
5350397 Palermo et al. Sep 1994 A
5350398 Pavcnik et al. Sep 1994 A
5364345 Lowery et al. Nov 1994 A
5370657 Irie Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5383887 Nadal Jan 1995 A
5413586 Dibie et al. May 1995 A
5415630 Gory et al. May 1995 A
5417708 Hall et al. May 1995 A
5451233 Yock Sep 1995 A
5458573 Summers Oct 1995 A
5522881 Lentz Jun 1996 A
5527338 Purdy Jun 1996 A
5531788 Dibie et al. Jul 1996 A
5549551 Peacock et al. Aug 1996 A
5549626 Miller et al. Aug 1996 A
5556414 Turi Sep 1996 A
5562698 Parker Oct 1996 A
5571135 Fraser et al. Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5601595 Smith Feb 1997 A
5624461 Mariant Apr 1997 A
5626605 Irie et al. May 1997 A
5630797 Diedrich et al. May 1997 A
5634942 Chevillon et al. Jun 1997 A
5649953 Lefebvre Jul 1997 A
5662703 Yurek et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5681347 Cathcart et al. Oct 1997 A
5690642 Osborne et al. Nov 1997 A
5690667 Gia Nov 1997 A
5693067 Purdy Dec 1997 A
5693087 Parodi Dec 1997 A
5695518 Laerum Dec 1997 A
5695519 Summers et al. Dec 1997 A
5700253 Parker Dec 1997 A
5709704 Nott et al. Jan 1998 A
5713853 Clark et al. Feb 1998 A
5720764 Naderlinger Feb 1998 A
5725550 Nadal Mar 1998 A
5738667 Solar Apr 1998 A
5746767 Smith May 1998 A
5755772 Evans et al. May 1998 A
5755790 Chevillon et al. May 1998 A
5766203 Imran et al. Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5769871 Mers et al. Jun 1998 A
5795322 Boudewijn Aug 1998 A
5800457 Gelbfish et al. Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814027 Hassett et al. Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5820592 Hammerslag Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5830230 Berryman et al. Nov 1998 A
5836968 Simon et al. Nov 1998 A
5836969 Kim et al. Nov 1998 A
5846260 Maahs Dec 1998 A
5853420 Chevillon et al. Dec 1998 A
5871537 Holman et al. Feb 1999 A
5876367 Kaganov et al. Mar 1999 A
5882329 Patterson et al. Mar 1999 A
5893869 Barnhart et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5895410 Forber et al. Apr 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911702 Romley et al. Jun 1999 A
5911704 Humes Jun 1999 A
5911717 Jacobsen et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5919224 Thompson et al. Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928260 Chine et al. Jul 1999 A
5928261 Ruiz Jul 1999 A
5938683 Lefebvre Aug 1999 A
5941896 Kerr Aug 1999 A
5944728 Bates Aug 1999 A
5947985 Imran Sep 1999 A
5947995 Samuels Sep 1999 A
5948017 Taheri Sep 1999 A
5951567 Javier, Jr. et al. Sep 1999 A
5954741 Fox Sep 1999 A
5954742 Osypka Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5968057 Taheri Oct 1999 A
5968071 Chevillon et al. Oct 1999 A
5972019 Engelson et al. Oct 1999 A
5976162 Doan et al. Nov 1999 A
5976172 Homsma et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5984947 Smith Nov 1999 A
5984965 Knapp et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6007558 Ravenscloth et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013093 Nott et al. Jan 2000 A
6015424 Rosenbluth et al. Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6036717 Mers Kelly et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059745 Gelbfish May 2000 A
6059813 Vrba et al. May 2000 A
6059814 Ladd May 2000 A
6063113 Kavteladze et al. May 2000 A
6066158 Engelson et al. May 2000 A
6067991 Forsell May 2000 A
6068645 Tu May 2000 A
6074357 Kaganov et al. Jun 2000 A
6077274 Ouchi et al. Jun 2000 A
6080178 Meglin Jun 2000 A
6083239 Addis Jul 2000 A
6086577 Ken et al. Jul 2000 A
6086605 Barbut et al. Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096053 Bates Aug 2000 A
6096070 Ragheb et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6106497 Wang Aug 2000 A
6126672 Berryman et al. Oct 2000 A
6126673 Kim et al. Oct 2000 A
6129739 Khosravi Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6146396 Konya et al. Nov 2000 A
6146404 Kim et al. Nov 2000 A
6152931 Nadal et al. Nov 2000 A
6152946 Broome et al. Nov 2000 A
6152947 Ambrisco et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6156062 McGuinness Dec 2000 A
6159230 Samuels Dec 2000 A
6165179 Cathcart et al. Dec 2000 A
6165198 McGurk et al. Dec 2000 A
6165199 Barbut Dec 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita et al. Jan 2001 B1
6168603 Leslie et al. Jan 2001 B1
6168610 Marin et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179860 Fulton, III et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6187025 Machek Feb 2001 B1
6193739 Chevillon et al. Feb 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6214025 Thistle et al. Apr 2001 B1
6214026 Lepak et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6224620 Maahs May 2001 B1
6231588 Zadno-Azizi May 2001 B1
6231589 Wessman et al. May 2001 B1
6235044 Root et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6238412 Dubrul et al. May 2001 B1
6241746 Bosma et al. Jun 2001 B1
6245012 Kleshinski Jun 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254550 McNamara et al. Jul 2001 B1
6254633 Pinchuk et al. Jul 2001 B1
6258026 Ravenscroft et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6264672 Fisher Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6267777 Bosma et al. Jul 2001 B1
6273900 Nott et al. Aug 2001 B1
6273901 Whitcher et al. Aug 2001 B1
6277125 Barry et al. Aug 2001 B1
6277126 Barry et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6280451 Bates et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6299604 Ragheb et al. Oct 2001 B1
6306163 Fitz Oct 2001 B1
6309399 Barbut et al. Oct 2001 B1
6312444 Barbut Nov 2001 B1
6319268 Ambrisco et al. Nov 2001 B1
6325815 Kusleika et al. Dec 2001 B1
6325816 Fulton, III et al. Dec 2001 B1
6328755 Marshall Dec 2001 B1
6331183 Suon Dec 2001 B1
6331184 Abrams Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6336934 Gilson et al. Jan 2002 B1
6338739 Datta et al. Jan 2002 B1
6340364 Kanesaka Jan 2002 B2
6342062 Suon et al. Jan 2002 B1
6342063 DeVries et al. Jan 2002 B1
6344048 Chin et al. Feb 2002 B1
6344049 Levinson et al. Feb 2002 B1
6346116 Brooks et al. Feb 2002 B1
6348041 Klint Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350271 Kurz et al. Feb 2002 B1
6355051 Sisskind et al. Mar 2002 B1
6358228 Tubman et al. Mar 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6361546 Khosravi Mar 2002 B1
6361547 Hieshima Mar 2002 B1
6364895 Greenhalgh Apr 2002 B1
6364896 Addis Apr 2002 B1
6368338 Konya et al. Apr 2002 B1
6371961 Osborne et al. Apr 2002 B1
6371969 Tsugita et al. Apr 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6379374 Hieshima et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6383146 Klint May 2002 B1
6383171 Gifford et al. May 2002 B1
6383174 Eder May 2002 B1
6383193 Cathcart et al. May 2002 B1
6383196 Leslie et al. May 2002 B1
6383205 Samson et al. May 2002 B1
6383206 Gillick et al. May 2002 B1
6391044 Yadav et al. May 2002 B1
6391045 Kim et al. May 2002 B1
6391052 Buirge et al. May 2002 B2
6395014 Macoviak et al. May 2002 B1
6402771 Palmer et al. Jun 2002 B1
6402772 Amplatz et al. Jun 2002 B1
6409742 Fulton, III et al. Jun 2002 B1
6413235 Parodi Jul 2002 B1
6416530 DeVries et al. Jul 2002 B2
6419686 McLeod et al. Jul 2002 B1
6423052 Escano Jul 2002 B1
6423086 Barbut et al. Jul 2002 B1
6425909 Dieck et al. Jul 2002 B1
6428557 Hilaire Aug 2002 B1
6428558 Jones et al. Aug 2002 B1
6428559 Johnson Aug 2002 B1
6432122 Gilson et al. Aug 2002 B1
6436112 Wensel et al. Aug 2002 B2
6436120 Meglin Aug 2002 B1
6436121 Blom Aug 2002 B1
6443926 Kletschka Sep 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443972 Bosma et al. Sep 2002 B1
6443979 Stalker et al. Sep 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6447531 Amplatz Sep 2002 B1
6454775 Demarais et al. Sep 2002 B1
6458139 Palmer et al. Oct 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6461370 Gray et al. Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6468291 Bates et al. Oct 2002 B2
6482222 Bruckheimer et al. Nov 2002 B1
6485456 Kletschka Nov 2002 B1
6485500 Kokish et al. Nov 2002 B1
6485501 Green Nov 2002 B1
6485502 Don Michael et al. Nov 2002 B2
6491712 O'Connor Dec 2002 B1
6494895 Addis Dec 2002 B2
6497709 Heath Dec 2002 B1
6499487 McKenzie et al. Dec 2002 B1
6500166 Zadno Azizi et al. Dec 2002 B1
6500191 Addis Dec 2002 B2
6502606 Klint Jan 2003 B2
6506203 Boyle et al. Jan 2003 B1
6506205 Goldberg et al. Jan 2003 B2
6508826 Murphy et al. Jan 2003 B2
6511492 Rosenbluth et al. Jan 2003 B1
6511496 Huter et al. Jan 2003 B1
6511497 Braun et al. Jan 2003 B1
6511503 Burkett et al. Jan 2003 B1
6514273 Voss et al. Feb 2003 B1
6517559 O'Connell Feb 2003 B1
6520978 Blackledge et al. Feb 2003 B1
6520983 Colgan et al. Feb 2003 B1
6527746 Oslund et al. Mar 2003 B1
6527791 Fisher Mar 2003 B2
6527962 Nadal Mar 2003 B1
6530935 Wensel et al. Mar 2003 B2
6530939 Hopkins et al. Mar 2003 B1
6530940 Fisher Mar 2003 B2
6533770 Lepulu et al. Mar 2003 B1
6533800 Barbut Mar 2003 B1
6537293 Berryman et al. Mar 2003 B1
6537294 Boyle et al. Mar 2003 B1
6537296 Levinson et al. Mar 2003 B2
6537297 Tsugita et al. Mar 2003 B2
6540722 Boyle et al. Apr 2003 B1
6540767 Walak et al. Apr 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544221 Kokish et al. Apr 2003 B1
6544276 Azizi Apr 2003 B1
6544278 Vrba et al. Apr 2003 B1
6544279 Hopkins et al. Apr 2003 B1
6544280 Daniel et al. Apr 2003 B1
6547759 Fisher Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551341 Boylan et al. Apr 2003 B2
6551342 Shen et al. Apr 2003 B1
6554849 Jones et al. Apr 2003 B1
6558404 Tsukernik May 2003 B2
6558405 McInnes May 2003 B1
6558406 Okada May 2003 B2
6562058 Seguin et al. May 2003 B2
6565591 Brady et al. May 2003 B2
6569147 Evans et al. May 2003 B1
6569183 Kim et al. May 2003 B1
6569184 Huter May 2003 B2
6575995 Huter et al. Jun 2003 B1
6575996 Denison et al. Jun 2003 B1
6575997 Palmer et al. Jun 2003 B1
6579303 Amplatz Jun 2003 B2
6582396 Parodi Jun 2003 B1
6582447 Patel et al. Jun 2003 B1
6582448 Boyle et al. Jun 2003 B1
6589227 Klint Jul 2003 B2
6589230 Gia et al. Jul 2003 B2
6589263 Hopkins et al. Jul 2003 B1
6589264 Barbut et al. Jul 2003 B1
6589265 Palmer et al. Jul 2003 B1
6589266 Whitcher et al. Jul 2003 B2
6592546 Barbut et al. Jul 2003 B1
6592606 Huter et al. Jul 2003 B2
6592616 Stack et al. Jul 2003 B1
6595983 Voda Jul 2003 B2
6596011 Johnson et al. Jul 2003 B2
6599275 Fischer, Jr. Jul 2003 B1
6599307 Huter et al. Jul 2003 B1
6599308 Amplatz Jul 2003 B2
6602271 Adams et al. Aug 2003 B2
6602273 Marshall Aug 2003 B2
6602280 Chobotov Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6607506 Kletschka Aug 2003 B2
6610077 Hancock et al. Aug 2003 B1
6611720 Hata et al. Aug 2003 B2
6613074 Mitelberg et al. Sep 2003 B1
6616679 Khosravi et al. Sep 2003 B1
6616680 Thielen Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6616682 Joergensen et al. Sep 2003 B2
6620148 Tsugita Sep 2003 B1
6620182 Khosravi et al. Sep 2003 B1
6623450 Dutta Sep 2003 B1
6623506 McGuckin, Jr. et al. Sep 2003 B2
6629953 Boyd Oct 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6635069 Teoh et al. Oct 2003 B1
6635070 Leeflang et al. Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6638294 Palmer Oct 2003 B1
6638372 Abrams et al. Oct 2003 B1
6641590 Palmer et al. Nov 2003 B1
6641605 Stergiopulos Nov 2003 B1
6645160 Heesch Nov 2003 B1
6645220 Huter et al. Nov 2003 B1
6645221 Richter Nov 2003 B1
6645222 Parodi et al. Nov 2003 B1
6645223 Boyle et al. Nov 2003 B2
6645224 Gilson et al. Nov 2003 B2
6652554 Wholey et al. Nov 2003 B1
6652557 MacDonald Nov 2003 B1
6652558 Patel et al. Nov 2003 B2
6656201 Ferrera et al. Dec 2003 B2
6656202 Papp et al. Dec 2003 B2
6656203 Roth et al. Dec 2003 B2
6656204 Ambrisco et al. Dec 2003 B2
6656351 Boyle Dec 2003 B2
6660021 Palmer et al. Dec 2003 B1
6663613 Evans et al. Dec 2003 B1
6663650 Sepetka et al. Dec 2003 B2
6663651 Krolik et al. Dec 2003 B2
6663652 Daniel et al. Dec 2003 B2
6676682 Tsugita et al. Jan 2004 B1
6679902 Boyle et al. Jan 2004 B1
6689144 Gerberding Feb 2004 B2
6695813 Boyle et al. Feb 2004 B1
6695865 Boyle et al. Feb 2004 B2
6702834 Boylan et al. Mar 2004 B1
6709450 Kang et al. Mar 2004 B2
6712835 Mazzocchi et al. Mar 2004 B2
6716207 Farnholtz Apr 2004 B2
6716231 Rafiee et al. Apr 2004 B1
6726701 Gilson et al. Apr 2004 B2
6730064 Ragheb et al. May 2004 B2
6755855 Yurek et al. Jun 2004 B2
6755856 Fierens et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6761727 Ladd Jul 2004 B1
6773446 Dwyer et al. Aug 2004 B1
6773448 Kusleika et al. Aug 2004 B2
6774278 Ragheb et al. Aug 2004 B1
6780175 Sachdeva et al. Aug 2004 B1
6793667 Hebert et al. Sep 2004 B2
6793668 Fisher Sep 2004 B1
6833002 Stack et al. Dec 2004 B2
6855154 Abdel-Gawwad Feb 2005 B2
6866677 Douk et al. Mar 2005 B2
6866680 Yassour et al. Mar 2005 B2
6872211 White et al. Mar 2005 B2
6878153 Linder et al. Apr 2005 B2
6896691 Boylan et al. May 2005 B2
6929709 Smith Aug 2005 B2
6932831 Forber Aug 2005 B2
6936059 Belef Aug 2005 B2
6939361 Kleshinski Sep 2005 B1
6942682 Vrba et al. Sep 2005 B2
6955685 Escamilla et al. Oct 2005 B2
6964670 Shah et al. Nov 2005 B1
6964674 Matsuura et al. Nov 2005 B1
6969396 Krolik et al. Nov 2005 B2
6974469 Broome et al. Dec 2005 B2
6974473 Barclay et al. Dec 2005 B2
6986784 Weiser et al. Jan 2006 B1
6991641 Diaz et al. Jan 2006 B2
7128073 van der Burg et al. Oct 2006 B1
7166120 Kusleika Jan 2007 B2
7174636 Lowe Feb 2007 B2
7189249 Hart et al. Mar 2007 B2
7204847 Gambale Apr 2007 B1
7220271 Clubb et al. May 2007 B2
7255687 Huang et al. Aug 2007 B2
7285130 Austin Oct 2007 B2
7303575 Ogle Dec 2007 B2
7306619 Palmer Dec 2007 B1
7371248 Dapolito et al. May 2008 B2
7393358 Malewicz Jul 2008 B2
7604649 McGuckin et al. Oct 2009 B2
7666216 Hogendijk et al. Feb 2010 B2
7708770 Linder et al. May 2010 B2
7731722 Lavelle et al. Jun 2010 B2
7731731 Abela Jun 2010 B2
7766934 Pal et al. Aug 2010 B2
20010000799 Wessman et al. May 2001 A1
20010001817 Humes May 2001 A1
20010005789 Root et al. Jun 2001 A1
20010007947 Kanesaka Jul 2001 A1
20010011181 DiMatteo Aug 2001 A1
20010011182 Dubrul et al. Aug 2001 A1
20010012951 Bates et al. Aug 2001 A1
20010016755 Addis Aug 2001 A1
20010020175 Yassour et al. Sep 2001 A1
20010023358 Tsukernik Sep 2001 A1
20010025187 Okada Sep 2001 A1
20010031980 Wensel et al. Oct 2001 A1
20010031981 Evans et al. Oct 2001 A1
20010031982 Peterson et al. Oct 2001 A1
20010039431 DeVries et al. Nov 2001 A1
20010039432 Whitcher et al. Nov 2001 A1
20010041908 Levinson et al. Nov 2001 A1
20010041909 Tsugita et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044632 Daniel et al. Nov 2001 A1
20010044634 Don Michael et al. Nov 2001 A1
20010053921 Jang Dec 2001 A1
20020002383 Sepetka et al. Jan 2002 A1
20020002384 Gilson et al. Jan 2002 A1
20020004667 Adams et al. Jan 2002 A1
20020016564 Courtney et al. Feb 2002 A1
20020016609 Wensel et al. Feb 2002 A1
20020022858 Demond et al. Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020026211 Khosravi et al. Feb 2002 A1
20020026212 Wholey et al. Feb 2002 A1
20020026213 Gilson et al. Feb 2002 A1
20020032460 Kusleika et al. Mar 2002 A1
20020032461 Marshall Mar 2002 A1
20020042626 Hanson et al. Apr 2002 A1
20020042627 Brady et al. Apr 2002 A1
20020045915 Balceta et al. Apr 2002 A1
20020045916 Gray et al. Apr 2002 A1
20020045918 Suon et al. Apr 2002 A1
20020049452 Kurz et al. Apr 2002 A1
20020049468 Streeter et al. Apr 2002 A1
20020052627 Boylan et al. May 2002 A1
20020058904 Boock et al. May 2002 A1
20020058911 Gilson et al. May 2002 A1
20020058963 Vale et al. May 2002 A1
20020058964 Addis May 2002 A1
20020062133 Gilson et al. May 2002 A1
20020062134 Barbut et al. May 2002 A1
20020062135 Mazzocchi et al. May 2002 A1
20020065507 Zadno-Azizi May 2002 A1
20020068954 Foster Jun 2002 A1
20020068955 Khosravi Jun 2002 A1
20020072764 Sepetka et al. Jun 2002 A1
20020072765 Mazzocchi et al. Jun 2002 A1
20020077596 McKenzie et al. Jun 2002 A1
20020082558 Samson et al. Jun 2002 A1
20020082639 Broome et al. Jun 2002 A1
20020087187 Mazzocchi et al. Jul 2002 A1
20020090389 Humes et al. Jul 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020091408 Sutton et al. Jul 2002 A1
20020091409 Sutton et al. Jul 2002 A1
20020095170 Krolik et al. Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020095172 Mazzocchi et al. Jul 2002 A1
20020095173 Mazzocchi et al. Jul 2002 A1
20020095174 Tsugita et al. Jul 2002 A1
20020099405 Yurek et al. Jul 2002 A1
20020099407 Becker et al. Jul 2002 A1
20020099435 Stinson Jul 2002 A1
20020103501 Diaz et al. Aug 2002 A1
20020107541 Vale et al. Aug 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020111648 Kusleika et al. Aug 2002 A1
20020111649 Russo et al. Aug 2002 A1
20020116024 Goldberg et al. Aug 2002 A1
20020120226 Beck Aug 2002 A1
20020120286 DoBrava et al. Aug 2002 A1
20020120287 Huter Aug 2002 A1
20020123720 Kusleika et al. Sep 2002 A1
20020123755 Lowe et al. Sep 2002 A1
20020123759 Amplatz Sep 2002 A1
20020123766 Seguin et al. Sep 2002 A1
20020128679 Turovskiy et al. Sep 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020128681 Broome et al. Sep 2002 A1
20020133191 Khosravi et al. Sep 2002 A1
20020133192 Kusleika et al. Sep 2002 A1
20020138094 Borillo et al. Sep 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020138096 Hieshima Sep 2002 A1
20020138097 Ostrovsky et al. Sep 2002 A1
20020143360 Douk et al. Oct 2002 A1
20020143361 Douk et al. Oct 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020151927 Douk et al. Oct 2002 A1
20020151928 Leslie et al. Oct 2002 A1
20020156520 Boylan et al. Oct 2002 A1
20020161389 Boyle et al. Oct 2002 A1
20020161390 Mouw Oct 2002 A1
20020161391 Murphy et al. Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161393 Demond et al. Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020161395 Douk et al. Oct 2002 A1
20020161396 Jang et al. Oct 2002 A1
20020165557 McAlister Nov 2002 A1
20020165573 Barbut Nov 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020165598 Wahr et al. Nov 2002 A1
20020169472 Douk et al. Nov 2002 A1
20020169474 Kusleika et al. Nov 2002 A1
20020173815 Hogendijk et al. Nov 2002 A1
20020173819 Leeflang et al. Nov 2002 A1
20020177872 Papp et al. Nov 2002 A1
20020177899 Eum et al. Nov 2002 A1
20020183781 Casey et al. Dec 2002 A1
20020183782 Tsugita et al. Dec 2002 A1
20020183783 Shadduck Dec 2002 A1
20020188313 Johnson et al. Dec 2002 A1
20020188314 Anderson et al. Dec 2002 A1
20020193824 Boylan et al. Dec 2002 A1
20020193825 McGuckin et al. Dec 2002 A1
20020193826 McGuckin et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20020193828 Griffin et al. Dec 2002 A1
20020198561 Amplatz Dec 2002 A1
20030004536 Boylan et al. Jan 2003 A1
20030004537 Boyle et al. Jan 2003 A1
20030004538 Secrest et al. Jan 2003 A1
20030004539 Linder et al. Jan 2003 A1
20030004540 Linder et al. Jan 2003 A1
20030004541 Wensel et al. Jan 2003 A1
20030004542 Wensel et al. Jan 2003 A1
20030009146 Muni et al. Jan 2003 A1
20030009189 Gilson et al. Jan 2003 A1
20030009190 Kletschka et al. Jan 2003 A1
20030009191 Wensel et al. Jan 2003 A1
20030014072 Wensel et al. Jan 2003 A1
20030018354 Roth et al. Jan 2003 A1
20030018355 Goto et al. Jan 2003 A1
20030023263 Krolik et al. Jan 2003 A1
20030023264 Dieck et al. Jan 2003 A1
20030023265 Forber Jan 2003 A1
20030032976 Boucck Feb 2003 A1
20030032977 Brady Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030045897 Huter et al. Mar 2003 A1
20030045898 Harrison et al. Mar 2003 A1
20030050662 Don Michael Mar 2003 A1
20030055452 Joergensen et al. Mar 2003 A1
20030055480 Fischell et al. Mar 2003 A1
20030060843 Boucher Mar 2003 A1
20030060844 Borillo et al. Mar 2003 A1
20030065354 Boyle et al. Apr 2003 A1
20030065355 Weber Apr 2003 A1
20030065356 Tsugita et al. Apr 2003 A1
20030069596 Eskuri Apr 2003 A1
20030073979 Naimark et al. Apr 2003 A1
20030074019 Gray et al. Apr 2003 A1
20030074054 Duerig et al. Apr 2003 A1
20030078614 Salahieh et al. Apr 2003 A1
20030083608 Evans et al. May 2003 A1
20030083692 Vrba et al. May 2003 A1
20030083693 Daniel et al. May 2003 A1
20030088211 Anderson et al. May 2003 A1
20030088266 Bowlin May 2003 A1
20030093110 Vale May 2003 A1
20030093112 Addis May 2003 A1
20030097094 Ouriel et al. May 2003 A1
20030097145 Goldberg et al. May 2003 A1
20030100917 Boyle et al. May 2003 A1
20030100918 Duane May 2003 A1
20030100919 Hopkins et al. May 2003 A1
20030105472 McAlister Jun 2003 A1
20030105484 Boyle et al. Jun 2003 A1
20030105486 Murphy et al. Jun 2003 A1
20030109824 Anderson et al. Jun 2003 A1
20030109897 Walak et al. Jun 2003 A1
20030109916 Don Michael Jun 2003 A1
20030114879 Euteneuer et al. Jun 2003 A1
20030114880 Hansen et al. Jun 2003 A1
20030120303 Boyle et al. Jun 2003 A1
20030120304 Kaganov et al. Jun 2003 A1
20030125764 Brady et al. Jul 2003 A1
20030125765 Blackledge et al. Jul 2003 A1
20030130680 Russell Jul 2003 A1
20030130681 Ungs Jul 2003 A1
20030130682 Broome et al. Jul 2003 A1
20030130684 Brady et al. Jul 2003 A1
20030130685 Daniel et al. Jul 2003 A1
20030130686 Daniel et al. Jul 2003 A1
20030130687 Daniel et al. Jul 2003 A1
20030130688 Daniel et al. Jul 2003 A1
20030135232 Douk et al. Jul 2003 A1
20030135233 Bates et al. Jul 2003 A1
20030139764 Levinson et al. Jul 2003 A1
20030139765 Patel et al. Jul 2003 A1
20030144685 Boyle et al. Jul 2003 A1
20030144686 Martinez et al. Jul 2003 A1
20030144687 Brady et al. Jul 2003 A1
20030144688 Brady et al. Jul 2003 A1
20030144689 Brady et al. Jul 2003 A1
20030150821 Bates et al. Aug 2003 A1
20030153935 Mialhe Aug 2003 A1
20030153942 Wang et al. Aug 2003 A1
20030153943 Michael et al. Aug 2003 A1
20030153944 Phung et al. Aug 2003 A1
20030153945 Patel et al. Aug 2003 A1
20030158518 Schonholz et al. Aug 2003 A1
20030158574 Esch et al. Aug 2003 A1
20030158575 Boylan et al. Aug 2003 A1
20030163158 White Aug 2003 A1
20030163159 Patel et al. Aug 2003 A1
20030167068 Amplatz Sep 2003 A1
20030167069 Gonzales et al. Sep 2003 A1
20030171769 Barbut Sep 2003 A1
20030171770 Kusleika et al. Sep 2003 A1
20030171771 Anderson et al. Sep 2003 A1
20030171772 Amplatz Sep 2003 A1
20030171800 Bicek et al. Sep 2003 A1
20030171803 Shimon Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030176885 Broome et al. Sep 2003 A1
20030176886 Wholey et al. Sep 2003 A1
20030176887 Petersen Sep 2003 A1
20030176888 O'Connell Sep 2003 A1
20030176889 Boyle et al. Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030181943 Daniel et al. Sep 2003 A1
20030187474 Keegan et al. Oct 2003 A1
20030187475 Tsugita et al. Oct 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030191492 Gellman et al. Oct 2003 A1
20030191493 Epstein et al. Oct 2003 A1
20030195554 Shen et al. Oct 2003 A1
20030195555 Khairkhahan et al. Oct 2003 A1
20030195556 Stack et al. Oct 2003 A1
20030199819 Beck Oct 2003 A1
20030199917 Knudson et al. Oct 2003 A1
20030199918 Patel et al. Oct 2003 A1
20030199919 Palmer et al. Oct 2003 A1
20030199920 Boylan et al. Oct 2003 A1
20030199921 Palmer et al. Oct 2003 A1
20030204168 Bosma et al. Oct 2003 A1
20030204202 Palmer et al. Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20030208222 Zadno-Azizi Nov 2003 A1
20030208224 Broome Nov 2003 A1
20030208225 Goll et al. Nov 2003 A1
20030208226 Bruckheimer et al. Nov 2003 A1
20030208227 Thomas Nov 2003 A1
20030208228 Gilson et al. Nov 2003 A1
20030208229 Kletschka Nov 2003 A1
20030208253 Beyer et al. Nov 2003 A1
20030212428 Richter Nov 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212431 Brady et al. Nov 2003 A1
20030212432 Khairkhahan et al. Nov 2003 A1
20030212433 Ambrisco et al. Nov 2003 A1
20030212434 Thielen Nov 2003 A1
20030216774 Larson Nov 2003 A1
20030220665 Eskuri et al. Nov 2003 A1
20030220667 Van der Burg et al. Nov 2003 A1
20030225418 Esksuri et al. Dec 2003 A1
20030225435 Huter et al. Dec 2003 A1
20030229374 Brady et al. Dec 2003 A1
20030233117 Adams et al. Dec 2003 A1
20040006364 Ladd Jan 2004 A1
20040006365 Brady et al. Jan 2004 A1
20040006370 Tsugita Jan 2004 A1
20040015152 Day Jan 2004 A1
20040039412 Isshiki et al. Feb 2004 A1
20040049226 Keegan et al. Mar 2004 A1
20040054394 Lee Mar 2004 A1
20040054395 Lee et al. Mar 2004 A1
20040059372 Tsugita Mar 2004 A1
20040064067 Ward Apr 2004 A1
20040064179 Linder et al. Apr 2004 A1
20040068271 McAlister Apr 2004 A1
20040078044 Kear Apr 2004 A1
20040082962 Demarais et al. Apr 2004 A1
20040088038 Dehnad et al. May 2004 A1
20040093009 Denison et al. May 2004 A1
20040093012 Cully et al. May 2004 A1
20040093016 Root et al. May 2004 A1
20040093059 Lee et al. May 2004 A1
20040098022 Barone May 2004 A1
20040098026 Joergensen et al. May 2004 A1
20040098033 Leeflang et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040102719 Keith et al. May 2004 A1
20040106944 Daniel et al. Jun 2004 A1
20040116831 Vrba Jun 2004 A1
20040133232 Rosenbluth et al. Jul 2004 A1
20040138696 Drasler et al. Jul 2004 A1
20040153118 Clubb et al. Aug 2004 A1
20040158278 Becker et al. Aug 2004 A1
20040162576 Barbut et al. Aug 2004 A1
20040164030 Lowe et al. Aug 2004 A1
20040167567 Cano et al. Aug 2004 A1
20040176794 Khosravi Sep 2004 A1
20040176833 Pavcnik et al. Sep 2004 A1
20040199201 Kellett et al. Oct 2004 A1
20040199203 Oslund et al. Oct 2004 A1
20040204737 Boismier et al. Oct 2004 A1
20040215322 Kerr Oct 2004 A1
20040225321 Krolik et al. Nov 2004 A1
20040236369 Dubrul Nov 2004 A1
20050004663 Llanos et al. Jan 2005 A1
20050021125 Stack et al. Jan 2005 A1
20050027345 Horan et al. Feb 2005 A1
20050038468 Panetta et al. Feb 2005 A1
20050038503 Greenhaigh Feb 2005 A1
20050043743 Dennis Feb 2005 A1
20050043756 Lavelle et al. Feb 2005 A1
20050043780 Gifford et al. Feb 2005 A1
20050049668 Jones et al. Mar 2005 A1
20050126979 Lowe et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050149110 Wholey et al. Jul 2005 A1
20050165480 Jordan et al. Jul 2005 A1
20050177186 Cully et al. Aug 2005 A1
20050177246 Datta et al. Aug 2005 A1
20050197688 Theron et al. Sep 2005 A1
20050209634 Brady et al. Sep 2005 A1
20050216053 Douk et al. Sep 2005 A1
20050217767 Barvosa-Carter et al. Oct 2005 A1
20050228474 Laguna Oct 2005 A1
20060009790 Kleshinski et al. Jan 2006 A1
20060009798 Callister et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060025804 Krolik et al. Feb 2006 A1
20060030923 Gunderson Feb 2006 A1
20060074474 Theron Apr 2006 A1
20060100544 Ayala et al. May 2006 A1
20060100545 Ayala et al. May 2006 A1
20060142845 Molaei et al. Jun 2006 A1
20060161186 Hassler et al. Jul 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060184194 Pal et al. Aug 2006 A1
20060200221 Malewicz Sep 2006 A1
20060229660 Pal et al. Oct 2006 A1
20060264707 Kinney Nov 2006 A1
20060287667 Abela Dec 2006 A1
20060287668 Fawzi et al. Dec 2006 A1
20070038241 Pal Feb 2007 A1
20070066991 Magnuson Mar 2007 A1
20070100372 Schaeffer May 2007 A1
20070112374 Paul, Jr. et al. May 2007 A1
20070129752 Webler et al. Jun 2007 A1
20070149996 Coughlin Jun 2007 A1
20070167974 Cully et al. Jul 2007 A1
20070185521 Bui et al. Aug 2007 A1
20070250108 Boyle et al. Oct 2007 A1
20070288054 Tanaka et al. Dec 2007 A1
20080015518 Huang et al. Jan 2008 A1
20080027481 Gilson et al. Jan 2008 A1
20080103522 Steingisser et al. May 2008 A1
20080154236 Elkins et al. Jun 2008 A1
20080167629 Dann et al. Jul 2008 A1
20080255587 Cully et al. Oct 2008 A1
20080255606 Mitra et al. Oct 2008 A1
20080262337 Falwell et al. Oct 2008 A1
20080275569 Lesh Nov 2008 A1
Foreign Referenced Citations (13)
Number Date Country
3429850 Feb 1986 DE
1127556 Aug 2001 EP
1310219 May 2003 EP
1516601 Mar 2005 EP
1557137 Jul 2005 EP
WO 9203097 Mar 1992 WO
WO 9610591 Apr 1996 WO
WO 9916382 Apr 1999 WO
WO 9923976 May 1999 WO
WO 9944510 Sep 1999 WO
WO 0182831 Nov 2001 WO
WO 03077799 Sep 2003 WO
WO 2006138391 Dec 2006 WO
Non-Patent Literature Citations (8)
Entry
Grummon, David S. et al., Appl. Phys. Lett., 82, 2727 (2003), pp. 2727.
Rubicon Embolic Filter, The Next Generation of EM, Rubicon Medical, www.rubiconmed.com.
Heeschen et al., Nature Medicine 7 (2001), No. 7, pp. 833-839.
Johnson et al., Circulation Research 94 (2004), No. 2, pp. 262-268.
International Search Report and Written Opinion for PCT/US2007/020300.
Brochure, “Shuttle Select ™ System for Carotid Artery Access,” (2004), pp. 1-3.
Brochure, “Slip-Cath® Angiographic Selective Catheters,” (2004), pp. 1-6.
Finol, E.A. et al., “Performance Assessment of Embolic Protection Filters for Carotid Artery Stenting,” Modelling in Medicine and Biology IV, (2005), vol. 8, pp. 133.
Related Publications (1)
Number Date Country
20060223386 A1 Oct 2006 US
Provisional Applications (1)
Number Date Country
60661731 Mar 2005 US